ICTRP Search Portal

Main

Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.

Register:	ClinicalTrials.gov
Last refreshed on:	24 April 2023
Main ID:	NCT02604732
Date of registration:	10/11/2015
Prospective Registration:	Yes
Primary sponsor:	National University Hospital, Singapore
Public title:	Pre-operative Withdrawal of Aspirin in Laparoscopic Inguinal Hernia Repair
Scientific title:	Randomized Controlled Trial on Pre-operative Withdrawal Versus no Withdrawal of Aspirin in Laparoscopic Inguinal Hernia Repair
Date of first enrolment:	April 1, 2016
Target sample size:	100
Recruitment status:	Recruiting
URL:	https://clinicaltrials.gov/show/NCT02604732
Study type:	Interventional
Study design:	Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Other. Masking: Double (Care Provider, Outcomes Assessor).
Phase:	N/A

Countries of recruitment
Singapore

Contacts

Name:	Davide Lomanto, MD PhD
Address:
Telephone:	+6567725903
Email:	surdl@nus.edu.sg
Affiliation:

Name:	Davide Lomanto, MD PhD
Address:
Telephone:
Email:
Affiliation:	National University Hospital, Singapore

Name:	Davide Lomanto, MD PhD
Address:
Telephone:	+6567725903
Email:	surdl@nus.edu.sg
Affiliation:

Key inclusion & exclusion criteria

Inclusion Criteria:

- Patients with a diagnosis of inguinal hernia undergoing laparoscopic repair

- Age 21-80 years

- Patients taking Aspirin

- BMI 18-30

Exclusion Criteria:

- Age <21 and >80years

- Recurrent inguinal hernia

- Coagulopathy

- Patients who can't stop Aspirin

- BMI <18 and >30

Age minimum: 21 Years
Age maximum: 80 Years
Gender: All

Health Condition(s) or Problem(s) studied

Inguinal Hernia

Intervention(s)

Procedure: Laparoscopic inguinal hernia repair with perioperative Aspirin

Procedure: Laparoscopic inguinal hernia repair without perioperative Aspirin

Primary Outcome(s)

Incidence of hematoma [Time Frame: 24 hours]

Secondary Outcome(s)

Incidence of hematoma requiring intervention [Time Frame: 30 days]

Incidence of seroma [Time Frame: 24 hours]

Secondary ID(s)

2015/00512

Source(s) of Monetary Support

Please refer to primary and secondary sponsors

Secondary Sponsor(s)

Ethics review

Results

Results available:
Date Posted:
Date Completed:
URL:

Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.